In consultation: Guidance and quality standards
Showing 11 to 15 of 15
| Title | Consultation | Type | Consultation end date |
|---|---|---|---|
| Pimicotinib for treating tenosynovial giant cell tumours when systemic treatment is needed [ID6647] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Decitabine–cedazuridine with venetoclax for treating acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance | |
| MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor | Draft scope consultation | Interventional procedures guidance | |
| Baxdrostat for treating uncontrolled or resistant hypertension [ID6623] | Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators | Technology appraisal guidance |